Iron overload in COVID-19, page-2

If Sinclair would be successful and get ATH434 approved in COVID infection (some kind of special approval), it would be a much quicker route to get ATH434 to the pharmacy. The present route is a bit complicated ( ph2 study in MSA population) and so it takes a lot of time.

He has written:
1. Why does COVID-19 disproportionately affect older people?, posted earlier, published at the end of April
2. Now this "Can artificial intelligence....." paper.

Then you can listen to his talks on YouTube and he tells that everybody in Havard is studying COVID. He has these 2 drugs PBT2 and ATH434 and he is an expert in aging understanding the role of iron, mitochondrion, and sirtuins better than anybody.

IMO if he can get a bit help from "artificial intelligence", he could well get something happening with his normal intelligence with these 2 products. Iron overload is clear in the severe phase of COVID and PBT2 has been killing viruses decades ago, if you classify it to be almost the same as Vioform, killing viruses, bacteria, and protozoa and now lately even antibiotic-resistant bacteria which can also be a problem in COVID infections of old people coming from care centers.